35
Participants
Start Date
July 28, 2011
Primary Completion Date
April 20, 2017
Study Completion Date
April 10, 2018
Dexmedetomidine
"Dexmedetomidine will be given maximal 72 hours. In case analgosedation is still needed after stop of the dexmedetomidine infusion, the treatment is switched to conventional analgosedation regimens.~Additional drugs are given to every inadequately sedated-painful patient (assessed by regular Comfort-neo and Numeric Rating Scale scoring). In case of oversedation or adverse drug events (hypotension, bradycardia), a downtitration (or stop) of the dexmedetomidine infusion is needed."
AZ Bruges, Bruges
Ghent University Hospital, Ghent
UZ Leuven, Leuven
Orion Corporation, Orion Pharma
INDUSTRY
University Hospital, Ghent
OTHER